Shanghai Sonyt Biotechnology Co., Ltd. yog ib qho ntawm cov ua lag luam thiab cov neeg muag khoom ntawm cas: 275371-94-3: taspoglutide hauv Suav teb, kuj txhawb kev pabcuam kev cai. Txais tos rau cov lag luam wholesale bulk zoo cas: 275371-94-3: taspoglutide los ntawm peb lub hoobkas. Tiv tauj peb kom paub meej ntxiv.
| Khoom npe | CAS: 275371-94-3: Taspoglutide |
| Kev piav qhia | Taspoglutide yog ib tug tshiab - tiam ntev - ua glucagon -zoo li peptide-1 (GLP-1) receptor agonist. Nws khi rau GLP-1 receptors nrog siab affinity, ua kom lub hauv paus cAMP teeb liab txoj hauv kev, thiab siv ntau yam cuam tshuam nrog rau cov piam thaj- nyob ntawm insulin secretion, glucagon tso tawm inhibition, qeeb plab hnyuv plab thiab qab los noj mov, txhim kho glycemic tswj thaum txo lub cev hnyav. Nrog Aib site-kev hloov pauv tshwj xeeb thiab kev hloov pauv ntawm fatty acid sab saw, nws tau txhim kho peptidase zoo heev thiab ua kom ntev hauv vivo ib nrab-lub neej, txhawb kev tswj hwm ib lub lim tiam. Hauv hom 2 mob ntshav qab zib mellitus thiab cov tsiaj rog rog, nws koob tshuaj-raws li txo cov ntshav qabzib thiab lub cev hnyav. Nws yog cov cuab yeej tseem ceeb peptide rau hom 2 mob ntshav qab zib hom kev tshawb fawb thiab kev txhim kho tshuaj GLP-1 peptide ntev. |
| Peptide Purity (HPLC, %) | 95% / 98% / 99% |
| Dawb puag molecular mis | C₁₅₄H₂₅₀N₄₂O₄₇ |
| Dawb puag molecular hnyav (Da) | 3433.87, siab dua rau daim ntawv ntsev |
| Hom qauv | Linear modified peptide, Aib mutation + fatty acid side chain modification, dawb peptide / acetate ntsev |
Product Basic Information Table
| Khoom Lub Npe Lus Askiv | Product Abbreviation / Alias | Function Tags (comma-sib cais) | Core Structure | Molecular Formula | Exact Mass (Da) | Qhov nruab nrab MW (Da) | Daim ntawv ntsev | Ntev (aa) |
| Taspoglutide | Taspoglutide; ntev - ua yeeb yam GLP-1 analog | Ntev - ua haujlwm GLP-1 receptor agonist, txo qis qabzib & poob phaus, DPP-4 tiv taus, ncua sijhawm noj tshuaj | GLP-1 analog; Aib kev hloov pauv ntawm txoj hauj lwm 8 resists DPP-4 degradation, fatty acid side chain modifications prolongs in vivo ib nrab-lub neej, xaiv activates GLP-1 receptors. | Dawb puag: C₁₅₄H₂₅₀N₄₂O₄₇ | 3431.84 | 3433.87 | Dawb peptide / acetate | 30 |
Physicochemical Solubility & Cia Parameters
| Khoom Code | Qhov tshwm sim | Ntev - Lub Sij Hawm Cia | Luv - Lub Sij Hawm Cia | Kev daws teeb meem | Khoom hmoov ruaj khov |
| PEB-TAS001 | hmoov dawb | Khaws ntawm -20 degree, kaw, qhuav thiab tiv thaiv los ntawm lub teeb, hauv qab cua nitrogen. Aliquot kom tsis txhob rov qab khov-thaw mus. | ruaj khov rau 2 xyoos ntawm 2-8℃nyob rau hauv kaw qhuav; ruaj khov rau luv luv -lub sij hawm shipping ntawm ambient kub, haum rau chav tsev kub logistics. | ruaj khov rau 7 hnub ntawm 4 degree. Solubility: ~ 100 mg / mL hauv DMSO (yuav tsum tau sonication); me ntsis soluble hauv dej ntshiab. Npaj aqueous tov los ntawm serial dilution los ntawm DMSO Tshuag. Fatty acid sab saw nyhav ua rau peptide aggregation; zam rov qab khov -thaw. | ruaj khov rau 3 xyoos ntawm -20℃thiab 2 xyoos ntawm 4 degree, qhuav thiab tiv thaiv los ntawm lub teeb. |
Functional Description
| Khoom Code | Frontend Short Summary (rau cov npe tshawb nrhiav) | Cov lus piav qhia txog kev ua haujlwm lom neeg lom neeg | Cov cheeb tsam tshawb fawb (comma- cais) | Lub Hom Phiaj / Txoj Kev |
| PEB-TAS001 | Aib-mutated ntev- ua yeeb yam GLP-1 agonist nrog lub zog txo cov piam thaj thiab poob phaus rau noj txhua lub lim tiam | Taspoglutide yog ib tug tshiab - tiam ntev - ua glucagon -zoo li peptide-1 (GLP-1) receptor agonist. Nws khi rau GLP-1 receptors nrog siab affinity, ua kom lub hauv paus cAMP teeb liab txoj hauv kev, thiab siv ntau yam cuam tshuam nrog rau cov piam thaj- nyob ntawm insulin secretion, glucagon tso tawm inhibition, qeeb plab hnyuv plab thiab qab los noj mov, txhim kho glycemic tswj thaum txo lub cev hnyav. Nrog Aib site-kev hloov pauv tshwj xeeb thiab kev hloov pauv ntawm fatty acid sab saw, nws tau txhim kho peptidase zoo heev thiab ua kom ntev hauv vivo ib nrab-lub neej, txhawb kev tswj hwm ib lub lim tiam. Hauv hom 2 mob ntshav qab zib mellitus thiab cov tsiaj rog rog, nws koob tshuaj-raws li txo cov ntshav qabzib thiab lub cev hnyav. Nws yog cov cuab yeej tseem ceeb peptide rau hom 2 mob ntshav qab zib hom kev tshawb fawb thiab kev txhim kho tshuaj GLP-1 peptide ntev. | Hom 2 mob ntshav qab zib mellitus mechanism kev tshawb fawb, kev tshawb fawb kev rog, ntev -kev txhim kho cov tshuaj peptide, GLP-1 receptor kev ua haujlwm, kev tswj cov piam thaj & lipid metabolism | Glucagon-zoo li peptide 1 receptor (GLP-1R); Glucose metabolism hauv kev tswj hwm lub plab zom mov thiab inhibition txoj hauv kev |
Cim npe nrov: CAS: 275371-94-3: Taspoglutide, Tuam Tshoj CAS: 275371-94-3: Taspoglutide manufacturers, lwm tus neeg, Hoobkas
